卖小鼠的百奥塞图冲刺“A+H”,实控人夫妇竟“预制”股权质押?

银莕财经
Sep 22

在历经两年零三个月,递交4版招股书后,百奥赛图(北京)医药科技股份有限公司(以下简称“百奥赛图”)将迎来上会。上交所官网显示,百奥赛图将于9月24日上会接受审议。银莕财经注意到,这家以实验鼠销售贡献近半营收的企业,资金需求始终处于高位,自2022年9月在港股上市募资约4.71亿港元后,仅时隔9个月,就又在2023年6月递表A股,计划再募11.85亿元。且与公司融资同步,百奥赛图实控人沈月雷、倪健...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10